FR2150816A1 - - Google Patents

Info

Publication number
FR2150816A1
FR2150816A1 FR7229858A FR7229858A FR2150816A1 FR 2150816 A1 FR2150816 A1 FR 2150816A1 FR 7229858 A FR7229858 A FR 7229858A FR 7229858 A FR7229858 A FR 7229858A FR 2150816 A1 FR2150816 A1 FR 2150816A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7229858A
Other languages
French (fr)
Other versions
FR2150816B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Publication of FR2150816A1 publication Critical patent/FR2150816A1/fr
Application granted granted Critical
Publication of FR2150816B1 publication Critical patent/FR2150816B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7229858A 1971-08-21 1972-08-21 Expired FR2150816B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6372271A JPS5614663B2 (enExample) 1971-08-21 1971-08-21

Publications (2)

Publication Number Publication Date
FR2150816A1 true FR2150816A1 (enExample) 1973-04-13
FR2150816B1 FR2150816B1 (enExample) 1976-07-02

Family

ID=13237559

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7229858A Expired FR2150816B1 (enExample) 1971-08-21 1972-08-21

Country Status (5)

Country Link
US (1) US3929765A (enExample)
JP (1) JPS5614663B2 (enExample)
DE (1) DE2241097A1 (enExample)
FR (1) FR2150816B1 (enExample)
GB (1) GB1393449A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560194A1 (fr) * 1984-02-27 1985-08-30 Midy Spa 3-aminoazetidine, ses sels, procede pour leur preparation et intermediaires de synthese
EP0406112A1 (fr) * 1989-06-29 1991-01-02 Laboratorios Del Dr. Esteve, S.A. 1-Benzhydrylazétidines, leur préparation et leur application comme intermédiaires pour la préparation de composés à activité antimicrobienne
WO1999019297A1 (en) * 1997-10-15 1999-04-22 Coelacanth Chemical Corporation Synthesis of azetidine derivatives

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888773A (en) * 1972-04-27 1975-06-10 Mobil Oil Corp Nitrogen compounds linked to a heterocyclic ring as multifunctional additives in fuel and lubricant compositions
US4120968A (en) * 1975-07-31 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic alkylaminocyclobutenediones
US4727152A (en) * 1982-09-30 1988-02-23 A. H. Robins Company, Inc. Intermediates useful in the preparation of fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
WO2000063168A1 (en) * 1999-04-16 2000-10-26 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
US7737145B2 (en) 2005-12-29 2010-06-15 Estrellita Pharmaceuticals, Llc Diamine derivatives as inhibitors of leukotriene A4 hydrolase
KR101426408B1 (ko) * 2013-02-19 2014-08-07 한국과학기술연구원 4각 고리 질소 화합물, 이를 포함하는 우울증, 정신 질환, 조루증, 또는 신경병증성 통증의 예방 또는 치료용 약학 조성물, 및 상기 약학 조성물을 포함하는 제제
CA2905340C (en) 2013-03-12 2022-05-31 Celtaxsys, Inc. Low dose oral formulations of acebilustat
MX2015011677A (es) 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
JP6534650B2 (ja) 2013-03-14 2019-06-26 セルタクシス，インコーポレイテッド ロイコトリエンａ４加水分解酵素の阻害剤
WO2019232306A1 (en) 2018-05-31 2019-12-05 Celtaxsys, Inc. Method of reducing pulmonary exacerbations in respiratory disease patients

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481920A (en) * 1965-10-22 1969-12-02 Lilly Co Eli Azetidinones

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2560194A1 (fr) * 1984-02-27 1985-08-30 Midy Spa 3-aminoazetidine, ses sels, procede pour leur preparation et intermediaires de synthese
EP0155870A1 (fr) * 1984-02-27 1985-09-25 Sanofi 3-aminoazétidine, ses sels, procédé pour leur préparation et intermédiaires de synthèse
US4822895A (en) * 1984-02-27 1989-04-18 Societe Anonyme - Sanofi 3-aminoazetidine, its salts and intermediates of synthesis
EP0406112A1 (fr) * 1989-06-29 1991-01-02 Laboratorios Del Dr. Esteve, S.A. 1-Benzhydrylazétidines, leur préparation et leur application comme intermédiaires pour la préparation de composés à activité antimicrobienne
FR2649100A1 (fr) * 1989-06-29 1991-01-04 Esteve Labor Dr Nouvelles azetidines, leur preparation et leur application comme intermediaires pour la preparation de composes avec activite antimicrobienne
US5073646A (en) * 1989-06-29 1991-12-17 Laboratorios Del Dr. Esteve, S.A. Substituted 1-diphenylmethyl azetidines
WO1999019297A1 (en) * 1997-10-15 1999-04-22 Coelacanth Chemical Corporation Synthesis of azetidine derivatives

Also Published As

Publication number Publication date
GB1393449A (en) 1975-05-07
FR2150816B1 (enExample) 1976-07-02
DE2241097A1 (de) 1973-03-08
JPS5614663B2 (enExample) 1981-04-06
JPS4829758A (enExample) 1973-04-19
US3929765A (en) 1975-12-30

Similar Documents

Publication Publication Date Title
JPS5614663B2 (enExample)
AU460471B2 (enExample)
AU3005371A (enExample)
AU2941471A (enExample)
AU2952271A (enExample)
AU2894671A (enExample)
AU2885171A (enExample)
AU2930871A (enExample)
AU2875571A (enExample)
AU2854371A (enExample)
AU2837671A (enExample)
AU2907471A (enExample)
AU2927871A (enExample)
AU2880771A (enExample)
AU2938071A (enExample)
AU2940971A (enExample)
AU2415871A (enExample)
AU2963771A (enExample)
AU2836771A (enExample)
AU3025871A (enExample)
AU3038671A (enExample)
CH559328A5 (enExample)
CH1138972A4 (enExample)
BG16828A1 (enExample)
BG16710A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse